HHS Selects 15 New Drugs for Medicare Part D Price Negotiations
As part of the Inflation Reduction Act, price negotiations with manufacturers will begin this year, with reduced prices expected to take effect in 2027.
Medicare to Negotiate Prices for 15 More Drugs, Including Ozempic
Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for older adults and people with disabilities.
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
The talks around drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that go into effect in 2027.
Medicare targets 15 more drugs for price negotiations — including Ozempic
On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in Medicare.
Yes, Trump rescinded Biden's order to lower prescription drug costs for people on Medicare and Medicaid
The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started, so current drug prices are unaffected.
Latest Medicare price drug negotiations includes Ozempic, Wegovy
Drugs used to treat cancer, diabetes and other chronic conditions are among 15 picked for negotiations that could result in lower prices for patients, the Department of Health and Human Services confirmed Friday.
Government picks 15 more prescription drugs for Medicare price negotiation
The U.S. Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), has selected 15 additional drugs for pr
Trump Ends Push To Slash Prescription Drug Costs
One of those now-cancelled policies directed Medicare to investigate ways to slash drug costs, including the possibility of a $2 monthly out-of-pocket cap on some generic medications. Monday's actions also follow through on a key goal of Trump's first term -- weakening the Affordable Care Act.
Trump reverses Biden policies on drug pricing and Obamacare
As President Donald Trump’s health care agenda for a second term takes shape, it’s becoming clear that many Biden-era policies won’t make the cut.
Trump Order Walks Back Biden-Era Effort To Lower Prescription Drug Prices. Here's Context
On Day 1 of his second term of office, Trump rescinded Biden's Executive Order 14087, "Lowering Prescription Drug Costs for Americans." Trump's action ha
Trump cancels Biden’s rule to help Medicare lower prescription drug prices
Drug pricing experts are not sure why rolling back drug pricing initiatives would be a day one priority for President Trump.
STAT10d
Former Trump White House, HHS aide Abe Sutton likely to lead Medicare, Medicaid innovation center
Abe Sutton, a health policy aide in the first Trump administration, is likely to be named head of the Center for Medicare and ...
MM&M7d
Ozempic and Wegovy make the list of the next 15 drugs in Medicare negotiations: HHS
Ozempic and Wegovy, Novo Nordisk’s GLP-1 drugs that treat diabetes and obesity, are on the list. Astellas Pharma’s prostate cancer drug, Xtandi, is also on the list — alongside AstraZeneca’s cancer ...
Xavier Becerra reflects on tenure as HHS secretary: 'We're leaving this country healthier and stronger'
Xavier Becerra is reflecting on tenure as HHS secretary. He told Scripps News, "We're leaving this country healthier and ...
Medicare’s 2025 Drug Negotiation List Includes Ozempic and Wegovy
The Centers for Medicare & Medicaid Services announced 15 new drugs it wants to lower the cost for, including popular, but ...
What does the health and human services secretary do?
The secretary of the Department of Health and Human Services, or HHS, plays a significant role in every American’s access to health care and in the nation’s overall well-being.
Alaska Public Media1d
Federal health agencies told to halt all external communications
In a memo obtained by NPR, acting Health Secretary Dorothy Fink forbade staff from public communications on most matters ...
Benefits Pro1d
Trump administration pauses most CDC, HHS and CMS communications
The exact scope and duration is clear, and one question is what will happen to release of CDC data that employers and insurers use in pricing.
Skilled Nursing News1d
Legal Defeat Remains Key Even if Legislative, Administrative Barriers Make Repeal of the Nursing Home Staffing Mandate Inevitable
In the aftermath of the Department of Health and Human Services’ (HHS) response to a pending lawsuit against the federal ...